Theodore R. Schroeder - May 31, 2022 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Chief Executive Officer, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Stock symbol
NBRV
Transactions as of
May 31, 2022
Transactions value $
-$22
Form type
4
Date filed
6/2/2022, 04:10 PM
Previous filing
May 9, 2022
Next filing
Jun 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability -$22 -107 -0.03% $0.21* 313K May 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.